Vanguard Group
RPID icon

Vanguard Group’s Rapid Micro Biosystems RPID Stock Holding History

Vanguard Group’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.84M Buy
978,781
+13,763
+1% +$47.8K ﹤0.01% 3446
2025
Q3 		$3.22M Buy
965,018
+60,655
+7% +$192K ﹤0.01% 3422
2025
Q2 		$3.12M Buy
904,363
+14,085
+2% +$40.9K ﹤0.01% 3373
2025
Q1 		$2.35M Buy
890,278
+169,145
+23% +$386K ﹤0.01% 3446
2024
Q4 		$649K Sell
721,133
-5,427
-0.7% -$5.46K ﹤0.01% 3875
2024
Q3 		$647K Sell
726,560
-1,924
-0.3% -$1.5K ﹤0.01% 3906
2024
Q2 		$481K Hold
728,484
– – ﹤0.01% 4021
2024
Q1 		$707K Buy
728,484
+110
+0% +$107 ﹤0.01% 3916
2023
Q4 		$539K Buy
728,374
+2,350
+0.3% +$2.4K ﹤0.01% 4005
2023
Q3 		$784K Sell
726,024
-3,576
-0.5% -$3.56K ﹤0.01% 3917
2023
Q2 		$730K Hold
729,600
– – ﹤0.01% 3997
2023
Q1 		$956K Hold
729,600
– – ﹤0.01% 3934
2022
Q4 		$824K Buy
729,600
+190
+0% +$460 ﹤0.01% 3976
2022
Q3 		$2.36M Buy
729,410
+49,640
+7% +$193K ﹤0.01% 3684
2022
Q2 		$2.92M Sell
679,770
-277,100
-29% -$1.29M ﹤0.01% 3641
2022
Q1 		$6.5M Buy
956,870
+558,028
+140% +$4.11M ﹤0.01% 3388
2021
Q4 		$4.24M Sell
398,842
-728,171
-65% -$11.4M ﹤0.01% 3699
2021
Q3 		$20.8M Buy
+1,127,013
New +$23.3M ﹤0.01% 2843

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EFA
Evernest Financial Advisors Carmel, Indiana $481M AUM 19.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group's RPID Position: Q4 2025 in Review

Vanguard Group increased its Rapid Micro Biosystems (RPID) stake by 1.4% in Q4 2025, buying an estimated $47.8K and bringing the position to 978,781 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3446.

Vanguard Group first reported a position in RPID in Q3 2021 and has held it in 18 quarters since. The position peaked at $20.8M in Q3 2021. 42 funds tracked by Wall St. Rank hold RPID as of Q4 2025.

  • Vanguard Group held 978,781 shares of Rapid Micro Biosystems worth $2.84M as of Q4 2025.
  • Vanguard Group bought 13,763 Rapid Micro Biosystems shares in Q4 2025, an estimated $47.8K.
  • Rapid Micro Biosystems made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3446 holding.
  • Vanguard Group first reported a position in Rapid Micro Biosystems in Q3 2021 and has held it in 18 quarters since.
  • Vanguard Group's Rapid Micro Biosystems position peaked at $20.8M in Q3 2021.
  • 42 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.